Navigation Links
Cara Therapeutics Files Registration Statement for Proposed Initial Public Offering
Date:11/11/2013

solicitation or sale would be unlawful, prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Cara Therapeutics  

Cara Therapeutics is a privately-held clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pain by selectively targeting kappa opioid receptors. Cara is developing a novel and proprietary class of product candidates that target the body's peripheral nervous system and have demonstrated efficacy in patients with moderate-to-severe pain without inducing many of the undesirable side effects typically associated with currently available pain therapeutics.


'/>"/>
SOURCE Cara Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Nektar Therapeutics Reports Financial Results for the Third Quarter of 2013
2. Echo Therapeutics Announces Third Quarter 2013 Financial Results
3. Halozyme Therapeutics To Present At The Credit Suisse Healthcare Conference
4. Orexigen Therapeutics Enters Into Agreement with Sanofi to Manufacture Contrave for Territories Outside North America
5. PDL BioPharma Provides $70 Million in Financing to Durata Therapeutics
6. PTC Therapeutics to Present at Credit Suisse Annual Health Care Conference
7. Alba Therapeutics Appoints Wendy Perrow Chief Executive Officer
8. Sorrento Therapeutics Enters into Antibody and Vaccine Development Alliance for the Prevention and Treatment of Obesity
9. Orexigen Therapeutics Announces Date of Third Quarter 2013 Financial Results Conference Call and Upcoming Presentation at Credit Suisse Healthcare Conference
10. Mast Therapeutics Reports Third Quarter 2013 Financial Results
11. Enlivex Therapeutics Publishes Positive Results from Phase I/II Clinical Trial for the Treatment of Bone Marrow Transplant Recipients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... LONDON , April 24, 2015 ... leader in the development of biosimilar therapies, spoke about ... today at the European Generics Association (EGA) annual European ... The company also announced the publication of ... paramount to achieving the full promise of biosimilars." ...
(Date:4/23/2015)... Ill. , April 24, 2015  AbbVie (NYSE: ... and Drug Administration (FDA) has accepted its New Drug ... all-oral, interferon-free, two direct-acting antiviral treatment of ombitasvir, paritaprevir, ... the treatment of adults with chronic genotype 4 (GT4) ... is the first all-oral, interferon-free therapy being evaluated by ...
(Date:4/23/2015)... , April 23, 2015 Once again, BeaconMedaes ... our commitment to patient safety. BeaconMedaes, priority ... against infectious disease. The next generation Zone ... gas sensors are now mounted in the assembly, allowing ... to open ceiling tiles potentially releasing dust spores and ...
Breaking Medicine Technology:Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 2Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 3Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 4Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 5Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 6Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 7U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 2U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 3U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 4U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 5U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 6U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 7BeaconMedaes launches new Zone Valve Box Assembly 2
... Masimo (Nasdaq: MASI ) announced today that it ... the period ended January 1, 2011, after the market closes on ... results will begin at 1:30 p.m. PT (4:30 p.m. ET) and ... and Mark P. de Raad, Executive Vice President and Chief Financial ...
... 2011 Get content from Bill & Melinda ... British Prime Minister David Cameron said today that ... to polio eradication. Mr. Cameron called on other ... as he announced the UK,s commitment that will ...
Cached Medicine Technology:Masimo to Report Fourth Quarter and Full Year 2010 Financial Results After Market Close on February 15, 2011 2Masimo to Report Fourth Quarter and Full Year 2010 Financial Results After Market Close on February 15, 2011 3
(Date:4/24/2015)... (PRWEB) April 24, 2015 Bird B Gone, ... residential applications now offers a complete line of bird control ... poultry farms. , New Flu Strains Threaten Pacific, Central and ... USDA post , a number of highly pathogenic avian ... The disease is often spread when wild birds enter poultry ...
(Date:4/24/2015)... As the nation recognizes the Month of the ... young men and women, the “Alaska – Forget Me ... presents a special training session on Adverse Childhood Experiences ... understanding of the effect of childhood trauma and, in ... and military – who provide services and support to ...
(Date:4/24/2015)... The Fastest Fat Loss Week Ever, released by Shaun ... Xtreme Fat Loss Diet, has been causing a lot of ... claims to help one lose belly fat in only 25 ... an investigative review. , "Our Fastest Fat Loss Week ... and experimenting with these methods on their clients with great ...
(Date:4/24/2015)... Hollywood, CA (PRWEB) April 24, 2015 ... of sitting down in an interview with ItsNotAboutMe.TV contributor ... Choice Recovery, a holistic treatment center for addiction, of ... awards ceremonies and festivals throughout the year, the EcoLuxe ... top providers of eco-friendly and socially conscious products and ...
(Date:4/24/2015)... April 24, 2015 Carinsurancequotesinfo.com has released ... post explaining how to qualify for auto insurance ... can qualify for auto insurance online, without having to ... explains that single parents can reduce their auto insurance ... article and properly explained. , Clients can now ...
Breaking Medicine News(10 mins):Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 2Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 3Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 4Health News:Coalition Presents Resiliency Training to Raise Awareness during Month of the Military Child (#MOTMC2015) 2Health News:Fastest Fat Loss Week Ever Review Revealed on Healthy & Fit Zone 2Health News:Karen Salkin Talks with Per Wickstrom at the 2015 EcoLuxe Lounge and the "Salute to the Oscars" Celebration 2Health News:Auto Insurance Discounts for Single Parents - How to Qualify for Low Rates 2
... the secure,remote service and support company today announced ... MCK ), has selected,the Axeda(R) ServiceLink solution ... which ensure safety and accuracy throughout the,medication use ... Axeda(R) Software Management,application will be used to remotely ...
... mission-critical outsourcing to Brooke Army Medical Center, ... SINT ), an information technology and network ... a new competitive task order under,the US Army,s ... Personnel Service and Support to provide,services to Brooke ...
... CHARLES TOWN, W.Va., Oct. 16 ReBuilder,Medical Technologies, ... agreed upon a Joint Venture with UFFE Medical, ... ReBuilder Medical,s unique home treatment for,the skin disease ... sometimes hundreds of pimple-like lesions that can take ...
... has been named one of 10 new centers in ... make critical treatment decisions about therapeutic products and interventions. ... for Healthcare Research and Quality,s Center for Education and ... and test systems to optimize drug choice, monitoring and ...
... Today, the International Association for the Study of Pain (IASP) ... to draw attention to the significant impact of chronic pain ... Lack of awareness of pain issues affecting women and ... of millions of women. , Chronic pain affects a ...
... Discovery could lead to new therapies , TUESDAY, Oct. 16 ... cancer has been identified. The finding about the Dmp1 ... at the cellular level to cause lung cancer. , The ... of human non-small-cell lung cancers and found that the ...
Cached Medicine News:Health News:Axeda Selected for Remote Monitoring and Service of Automation Technologies 2Health News:SI International Awarded $4 Million Army HRsolutions Task Order 2Health News:SI International Awarded $4 Million Army HRsolutions Task Order 3Health News:ReBuilder Medical Technologies, Inc. Announces UK Demand for Safe Molluscum Contagiosum Treatment Leads to Distribution Agreement with UFFE Medical, LTD. Expected 10% Sales Increase. 2Health News:ReBuilder Medical Technologies, Inc. Announces UK Demand for Safe Molluscum Contagiosum Treatment Leads to Distribution Agreement with UFFE Medical, LTD. Expected 10% Sales Increase. 3Health News:New UIC center to study drug choices, safety 2Health News:IASP declares the Global Year Against Pain in Women 2Health News:IASP declares the Global Year Against Pain in Women 3Health News:Researchers ID New Gene Linked to Lung Cancer 2
... Innovations' Instrument Manager (IM) is an instrument ... system that enables laboratories to work more ... as a data management solution that stands ... information system, filling those important gaps in ...
70 discs to investigate acquired color deficiency. Quantifies neutral zone characteristics of dyschromatopsia and evaluates the relative luminance....
... Products version of the Farnsworth 100 Hue Test ... scoring easy and reduces the potential for ... intact. ,The Farnsworth 100 Hue test from Richmond ... boxes, a tray, a durable laminated score template ...
... it is not the Flu? Streptococcus pneumoniae ... "flu-like" infections. The easy-to-use, rapid, urine-based test ... the new 4 hour guidelines. Rapid identification ... patient outcomes and lower overall health care ...
Medicine Products: